← Open Payments lookup

DANIEL ATTIAS: Open Payments

NPI 1811714017 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$623 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $40 · 2025 $623

Food & beverage: $623
CompanyPaymentsAmount
ABBVIE INC.9$265
Takeda Pharmaceuticals U.S.A., Inc.1$103
Boston Scientific Corporation2$98
Regeneron Healthcare Solutions, Inc.2$42
VIVUS LLC1$24
Collegium Pharmaceutical, Inc.1$23
Nalu Medical, Inc.1$22
Amgen Inc.1$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$16
Aimmune Therapeutics, Inc.1$14

Products named: CREON, ENTYVIO, Intracept, UBRELVY, DUPIXENT, LINZESS, RINVOQ, PANCREAZE.

Industry payments across FL — which companies pay providers there.